BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20848442)

  • 1. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
    Maahs MP; Azambuja AA; Campos MM; Salum FG; Cherubini K
    Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].
    Jarnbring F; Ulmner M; Blomlöf J; Ljungman P
    Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1741-3. PubMed ID: 16826719
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
    Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.
    López-Jornet P; Camacho-Alonso F; Molina-Miñano F; Gómez-García F; Vicente-Ortega V
    J Oral Pathol Med; 2010 Oct; 39(9):697-702. PubMed ID: 20819131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.
    Abtahi J; Agholme F; Sandberg O; Aspenberg P
    J Oral Pathol Med; 2012 Jul; 41(6):494-9. PubMed ID: 22268631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
    Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
    J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.
    Jimenez-Soriano Y; Bagan JV
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E88-91. PubMed ID: 15995577
    [No Abstract]   [Full Text] [Related]  

  • 10. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 11. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD; Obeid G
    J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.
    Bagan JV; Jimenez Y; Murillo J; Hernandez S; Poveda R; Sanchis JM; Diaz JM; Scully C
    Oral Oncol; 2006 Mar; 42(3):327-9. PubMed ID: 16275156
    [No Abstract]   [Full Text] [Related]  

  • 13. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].
    Lund T; Gregersen H; Vangsted A; Marker P; Abildgaard N
    Ugeskr Laeger; 2009 Jan; 171(1-2):50-2. PubMed ID: 19128568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
    Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L
    J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
    Edwards BJ; Gounder M; McKoy JM; Boyd I; Farrugia M; Migliorati C; Marx R; Ruggiero S; Dimopoulos M; Raisch DW; Singhal S; Carson K; Obadina E; Trifilio S; West D; Mehta J; Bennett CL
    Lancet Oncol; 2008 Dec; 9(12):1166-72. PubMed ID: 19038763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E; Sheehy C; Barry M; Carey J
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract]   [Full Text] [Related]  

  • 18. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw.
    Biasotto M; Chiandussi S; Zacchigna S; Moimas S; Dore F; Pozzato G; Cavalli F; Zanconati F; Contardo L; Giacca M; Di Lenarda R
    J Oral Pathol Med; 2010 May; 39(5):390-6. PubMed ID: 20202091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.